ArticleRSC advances2026
Application of poly-dl-methionine/gold nanoparticle-modified recycled battery graphite as an eco-friendly electrochemical sensor for the spasmolytic drug vincamine.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present work suggests the use of an economic, ultra-sensitive, and sustainable electrochemical sensor based on the electropolymerization of dl-methionine as a conducting polymeric film on a gold nanoparticle-modified battery graphite electrode, poly(dl-met)/AuNPs-BGE, for the analysis of vincamine (VIN), a natural alkaloid spasmolytic drug used for managing Alzheimer's, neurodegenerative, and normal aging-related cognitive diseases. The sensor exhibited a broad linear working range from 0.003 to 100 µM (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.